Inclusion Criteria:  ≥2 diagnoses (dx) of hypertension from either a community practitioner or/and from a hospital admission; on ≥1 oral antihypertensive medication; and average recorded systolic BP of <135 mmHg.  Exclusion Criteria:  ≥2 community dx of congestive heart failure, ≥1 dx of in hospital congestive heart failure, ≥1 dx of emergency visit of congestive heart failure, or prescription of furosemide in the last month; ≥2 community dx of benign prostate hypertrophy or ≥1 dx of in hospital benign prostate hypertrophy and the only antihypertensive prescribed in the last month is an alpha blocker; ≥2 community dx of essential tremor or ≥1 dx of in hospital essential tremor and the only antihypertensive prescribed in the last month is a beta blocker; ≥2 community dx of a migraine or ≥1 dx of in hospital migraine and the only antihypertensive prescribed in the last month is a beta blocker; ≥2 community dx of tachycardia/atrial fibrillation or ≥1 dx of in hospital tachycardia/atrial fibrillation and the only antihypertensive prescribed in the last month is a beta blocker and/or a calcium channel blocker; ≥2 community dx of coronary artery disease or ≥1 dx of in hospital coronary artery disease and the only antihypertensive prescribed in the last month is a beta blocker and/or a calcium channel blocker; the resident's physician declines to participate in the study; or the resident or legal guardian declines to participate in the study.